Effects of dopamine and dopamine-derived tetrahydroisoquinolines on Ca++-Mg++-ATPase
Ross, D.H.; Hamilton, M.G.
Progress in Clinical and Biological Research 90: 289-299
1982
ISSN/ISBN: 0361-7742 PMID: 6125948 Document Number: 191465
Document emailed within 1 workday
Related Documents
Maruyama, W.; Takahashi, T.; Minami, M.; Takahashi, A.; Dostert, P.; Nagatsu, T.; Naoi, M. 1993: Cytotoxicity of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines Advances in Neurology 60: 224-230Hess, W.; Klein, W.; Mueller-Busch, C.; Tarnow, J. 1979: Haemodynamic effects of dopamine and dopamine combined with nitroglycerin in patients subjected to coronary bypass surgery British Journal of Anaesthesia 51(11): 1063-1069
Pavoni, V.; Verri, M.; Ferraro, L.; Volta, C.A.; Paparella, L.; Capuzzo, M.; Pavanelli, L.; Buccoliero, C.; Beani, L.; Alvisi, R.; Gritti, G. 1998: Plasma dopamine concentration and effects of low dopamine doses on urinary output after major vascular surgery Kidney International. Suppl 66: S75-S80
Katzman, R.; Makman, M.H.; Ahn, H.S.; Mishra, R.K.; Gardner, E. 1977: Effects of drugs and lesions on dopamine-stimulated adenylate cyclase: evidence for different classes of dopamine receptors Transactions of the American Neurological Association 102: 76-79
Kuczenski, R.; Segal, D.S. 1992: Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine Journal of Pharmacology and Experimental Therapeutics 262(3): 1085-1094
Hillegaart, V.; Ahlenius, S.; Fowler, C.J.; Magnusson, O. 1988: Increased duration of dopamine receptor antagonist-induced effects on both behaviour and striatal dopamine turnover by repeated testing in rats Pharmacology and Toxicology 63(2): 114-117
Parker, E.M.; Cubeddu, L.X. 1986: Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores Journal of Pharmacology and Experimental Therapeutics 237(1): 179-192
Hoffmann, I.S.; Talmaciu, R.K.; Cubeddu, L.X. 1986: Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release Journal of Pharmacology and Experimental Therapeutics 238(2): 437-446
Hazard, R.; Renier-Cornec, A. 1973: Effects of cocaine on hypertension induced by dopamine (hydroxytyramine) and action on posthypophyse extracts on blood pressure effect induced by this dopamine previously treated with adrenalin antagonists Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 167(2): 226-228
Allen, E.; Pettigrew, A.; Frank, D.; Thompson, S.; Myers, C.; Yamashita, T.; Blumer, J.L. 1997: Alterations in dopamine clearance and catechol-O-methyltransferase activity by dopamine infusions in children Critical Care Medicine 25(1): 181-189
Wagner, G.C.; Ricaurte, G.A.; Johanson, C.E.; Schuster, C.R.; Seiden, L.S. 1980: Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate Neurology 30(5): 547-550
Shibata, O.; Yorozuya, Y.; Nagatani, A.; Shimada, M.; Haseba, S.; Gotoh, Y.; Honda, Y. 1986: Dopamine and norepinephrine concentrations in the human digestive tract following exogenous dopamine administration Masui. Japanese Journal of Anesthesiology 35(12): 1830-1835
Morelli, A.; Narducci, F.; Camardella, G.; Pelli, M.A.; Floridi, A.; Nenci, G.G. 1977: Dopamine uptake by platelets in hepatic encephalopathy; evidence for a possible depletion of brain dopamine Acta Hepato-Gastroenterologica 24(6): 405-410
Wustmann, C.; Rudolph, E.; Schwipper, U.; Ranacher, B.; Fischer, H.D.; Schmidt, J. 1982: Effect of nootropic drugs on the dopamine release and dopamine uptake in structures of the rat striatum Acta Biologica et Medica Germanica 41(6): 575-579
Woodruff, G.N.; Freedman, S.B.; Poat, J.A. 1980: Why does sulpiride not block the effect of dopamine on the dopamine-sensitive adenylate cyclase? Journal of Pharmacy and Pharmacology 32(11): 802-803
Fukuda, S.; Kobayashi, H.; Mochizuki, T.; Tanaka, M.; Yokoyama, Y.; Hattori, N. 1992: Plasma dopamine, urinary dopamine and their metabolites in chronic renal failure Nihon Jinzo Gakkai Shi 34(9): 1011-1017
Dwoskin, L.P.; Zahniser, N.R. 1986: Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors Journal of Pharmacology and Experimental Therapeutics 239(2): 442-453
Tadori, Y.; Kobayashi, H. 2014: The therapeutic plasma concentrations of antiparkinson dopamine agonists and their in vitro pharmacology at dopamine receptors Nihon Shinkei Seishin Yakurigaku Zasshi 34(5-6): 127-132
Kohli, J.D.; Weder, A.B.; Goldberg, L.I.; Ginos, J.Z. 1980: Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors Journal of Pharmacology and Experimental Therapeutics 213(2): 370-374
Lee, F.J.S.; Liu, F.; Pristupa, Z.B.; Niznik, H.B. 2018: Direct binding and functional coupling of α-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis FASEB Journal 15(6): 916-926